Drugs / L-377202
last change Nov 2001 re-read 3 minutes ago

L-377202

also known as L-377202-000H

Small molecule

Developed for
hormone-resistant prostate carcinoma
Investigated by
Merck Sharp & Dohme LLC · University of Alabama at Birmingham

Trials 1

19992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT00987753 Mar 1999 → Sep 2000 hormone-resistant prostate carcinoma University of Alabama at Birmingham Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as L-377202 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00987753 ↗
Known as L-377202-000H ChEMBL registry synonym — accepted as the source's own label CHEMBL3093499 ↗
Modality Small molecule — CHEMBL3093499 ↗